Tonix Pharmaceuticals Holding Corp.
TNXP
$17.82
$0.633.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.47% | -11.76% | -22.12% | 15.59% | -5.84% |
| Total Depreciation and Amortization | -20.27% | 8.82% | 52.17% | 109.79% | 242.46% |
| Total Amortization of Deferred Charges | -- | 268.91% | -- | -- | -- |
| Total Other Non-Cash Items | 468.08% | 536.13% | 488.70% | -79.33% | -4.72% |
| Change in Net Operating Assets | 16,600.00% | -105.12% | 23.10% | 27.06% | -1,650.00% |
| Cash from Operations | 40.27% | 32.69% | 28.30% | 13.26% | -4.03% |
| Capital Expenditure | 98.48% | 95.42% | 87.67% | 86.75% | 83.60% |
| Sale of Property, Plant, and Equipment | -- | -99.29% | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.59% | 98.35% | 96.71% | 20.01% | 39.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 577.42% | 237.03% | -25.89% | -75.59% | -77.69% |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -151.78% | 274.17% | 291.47% | 1,416.09% | 303.06% |
| Cash from Financing | 269.34% | 2,882.59% | 783.88% | -24.46% | -58.43% |
| Foreign Exchange rate Adjustments | 106.15% | 50.00% | 63.24% | 71.74% | 12.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 178.03% | 116.04% | 86.26% | 6.12% | -61.94% |